drugset / Trial / NCT04656730
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to asess the effects of Iberogast® (STW5) and Iberogast® N (STW5-II) in intestinal gas transit and abdominal symptoms of patients suffering from irritable bowel syndrome or functional dyspepsia.
Timeline
- Start
- 2020-09-03
- Primary completion
- 2023-01-31
- Completion
- 2023-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STW5 | Traditional medicine (herbal / TCM) | 20 unknown | Oral |
| Subject | STW5-II | Traditional medicine (herbal / TCM) | 20 unknown | Oral |